Cargando…
Transgenic LRRK2(R1441G) rats–a model for Parkinson disease?
Parkinson disease (PD) is the most common movement disorder, characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra. While the cause of this disease is largely unknown, a rare autosomal dominant familial form of PD is caused by a genetic mutation in the leucine...
Autores principales: | Shaikh, Komal T., Yang, Alvin, Youshin, Ekaterina, Schmid, Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435452/ https://www.ncbi.nlm.nih.gov/pubmed/26020005 http://dx.doi.org/10.7717/peerj.945 |
Ejemplares similares
-
Mitochondrial dysfunction and mitophagy defects in LRRK2-R1441C Parkinson’s disease models
por: Williamson, Matthew G, et al.
Publicado: (2023) -
A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene
por: Vinagre-Aragón, Ana, et al.
Publicado: (2021) -
68 and FX2149 Attenuate Mutant LRRK2-R1441C-Induced Neural Transport Impairment
por: Thomas, Joseph M., et al.
Publicado: (2017) -
LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity
por: Liu, Hui-Fang, et al.
Publicado: (2014) -
HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice
por: Kim, Taewoo, et al.
Publicado: (2019)